Marinus Pharmaceuticals Inc (MRNS)
1.41
+0.07
(+5.22%)
USD |
NASDAQ |
May 15, 13:00
Marinus Pharmaceuticals Gross Profit Margin (Quarterly): 90.16% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 90.16% |
December 31, 2023 | 87.66% |
September 30, 2023 | 93.80% |
June 30, 2023 | 93.65% |
March 31, 2023 | 98.02% |
December 31, 2022 | 95.92% |
Date | Value |
---|---|
September 30, 2022 | 97.95% |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | 85.39% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
85.39%
Minimum
Sep 2021
98.02%
Maximum
Mar 2023
92.82%
Average
93.73%
Median
Gross Profit Margin (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 90.70% |
Soligenix Inc | -- |
Actinium Pharmaceuticals Inc | -- |
Macrogenics Inc | 76.76% |
ADMA Biologics Inc | 47.77% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -368.3% |
Return on Assets | -77.55% |
Return on Invested Capital | -129.5% |
Profit Margin (Quarterly) | -503.6% |
Operating Margin (Quarterly) | -466.5% |
Return on Net Operating Assets | -1.08K% |